← SynDRA
FLUTICASONE FUROATE
SynDRA canonical compound SYN0018472 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | NR3C1 | NR3C2 | PGR |
|---|
| Mechanism of action | glucocorticoid receptor agonist |
|---|
| Indication | asthma |
|---|
| Disease area | pulmonary |
|---|
All known targets
- NR3C1
- NR3C2
- PGR
- Ar
- Nr3c1
- PLA2G4A
- CYP3A5
- CYP3A7
Mechanisms of action (all sources)
- NR3C1 AGONIST
- NR3C2 AGONIST
- PGR AGONIST
- NR3C1 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PTGS1
- HTR2C
- MC3R
- MAOA
- KCNH2
- HTR7
- HTR6
- HTR3A
- ACHE
- MLNR
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- MC4R
- NPY1R
- ADORA1
- NPY2R
- NR1I2
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4A
- PDE4D
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TACR2
- GHSR
- GCGR
- GABBR1
- CCKBR
- ADORA2A
- ADORA3
- ADRA1A
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Allergic Agents
- Anti-Asthmatic Agents
- Anti-Inflammatory Agents
- Bronchodilator Agents
- Dermatologic Agents
- Peripheral Nervous System Agents
- Respiratory System Agents
ATC classes
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
- R03B · OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
- D07A · CORTICOSTEROIDS, PLAIN
- ADRENERGICS, INHALANTS
Cross-references
Synonyms
- ARNUITY ELLIPTA
- BREO ELLIPTA
- FLONASE SENSIMIST ALLERGY RELIEF
- Flonase Sensimist
- TRELEGY ELLIPTA
- avamys
- veramyst
- Furoate de fluticasone
- Furoato de fluticasona
- Allermist
- Ennhale
- Furamist
- GSK 685 698
- GSK-685968
- GSK685968
- GW-685698X
- GW685698X
- Alisade
- Arnuity ellipta
- Avamys
- Flonase sensimist allergy relief
- Fluticasone furoate component of arnuity ellipta
- Fluticasone furoate component of breo ellipta
- Fluticasone furoate component of trelegy ellipta
- Relvar ellipta
- Trelegy ellipta
- Veramyst
- GW6
- GW-685698
- Veramyst (TN)
- Fluticasone furoate (JAN/USAN/INN)
- TRELEGY ELLIPTA COMPONENT FLUTICASONE FUROATE
- ARNUITY ELLIPTA COMPONENT FLUTICASONE FUROATE
- GW 685698X
- JS86977WNV
- BREO ELLIPTA COMPONENT FLUTICASONE FUROATE
- Arnuity Ellipta
Reported adverse events
- Headache
- Hypersensitivity
- Epistaxis
- Cataract
- Glaucoma
- Cough
- Pharyngitis
- Nausea
- Immunosuppression
- Rhinitis
- Infection
- Urticaria
Look up FLUTICASONE FUROATE in the interactive SynDRA portal →